Literature DB >> 24681158

The interplay between microRNAs and histone deacetylases in neurological diseases.

Megan W Bourassa1, Rajiv R Ratan2.   

Abstract

Neurological conditions, such as Alzheimer's disease and stroke, represent a prevalent group of devastating illnesses with few treatments. Each of these diseases or conditions is in part characterized by the dysregulation of many genes, including those that code for microRNAs (miRNAs) and histone deacetylases (HDACs). Recently, a complex relationship has been uncovered linking miRNAs and HDACs and their ability to regulate one another. This provides a new avenue for potential therapeutics as the ability to reinstate a careful balance between miRNA and HDACs has lead to improved outcomes in a number of in vitro and in vivo models of neurological conditions. In this review, we will discuss recent findings on the interplay between miRNAs and HDACs and its implications for pathogenesis and treatment of neurological conditions, including amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease and stroke.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Histone deacetylase; MicroRNA; Neurodegeneration; Neurological conditions

Mesh:

Substances:

Year:  2014        PMID: 24681158      PMCID: PMC4321688          DOI: 10.1016/j.neuint.2014.03.012

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  52 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

3.  MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice.

Authors:  Andrew H Williams; Gregorio Valdez; Viviana Moresi; Xiaoxia Qi; John McAnally; Jeffrey L Elliott; Rhonda Bassel-Duby; Joshua R Sanes; Eric N Olson
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

4.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

5.  Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers.

Authors:  Rulun Zhou; Peixiong Yuan; Yun Wang; Joshua G Hunsberger; Abdel Elkahloun; Yanling Wei; Patricia Damschroder-Williams; Jing Du; Guang Chen; Husseini K Manji
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

6.  A microRNA-based gene dysregulation pathway in Huntington's disease.

Authors:  Rory Johnson; Chiara Zuccato; Nikolai D Belyaev; Deborah J Guest; Elena Cattaneo; Noel J Buckley
Journal:  Neurobiol Dis       Date:  2007-11-13       Impact factor: 5.996

7.  MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion.

Authors:  Kandiah Jeyaseelan; Kai Ying Lim; Arunmozhiarasi Armugam
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

8.  SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease.

Authors:  Michal Mielcarek; Caroline L Benn; Sophie A Franklin; Donna L Smith; Ben Woodman; Paul A Marks; Gillian P Bates
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

9.  snoRNA, a novel precursor of microRNA in Giardia lamblia.

Authors:  Ashesh A Saraiya; Ching C Wang
Journal:  PLoS Pathog       Date:  2008-11-28       Impact factor: 6.823

10.  Sirtuin activators mimic caloric restriction and delay ageing in metazoans.

Authors:  Jason G Wood; Blanka Rogina; Siva Lavu; Konrad Howitz; Stephen L Helfand; Marc Tatar; David Sinclair
Journal:  Nature       Date:  2004-07-14       Impact factor: 69.504

View more
  11 in total

1.  Trehalose Attenuates Learning and Memory Impairments in Aged Rats via Overexpression of miR-181c.

Authors:  Bentolhoda Shafiei; Mohammad Shabani; Ali Afgar; Mohammad Amin Rajizadeh; Mahdieh Nazari-Robati
Journal:  Neurochem Res       Date:  2022-07-29       Impact factor: 4.414

2.  Involvement of upregulation of miR-210 in a rat epilepsy model.

Authors:  Licheng Chen; Hao Zheng; Shimeng Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-13       Impact factor: 2.570

Review 3.  Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents.

Authors:  Seyed Esmaeil Khoshnam; William Winlow; Yaghoob Farbood; Hadi Fathi Moghaddam; Maryam Farzaneh
Journal:  J Stroke       Date:  2017-05-08       Impact factor: 6.967

Review 4.  Epigenetics in Stroke Recovery.

Authors:  Haifa Kassis; Amjad Shehadah; Michael Chopp; Zheng Gang Zhang
Journal:  Genes (Basel)       Date:  2017-02-27       Impact factor: 4.096

Review 5.  The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets.

Authors:  Weilin Xu; Liansheng Gao; Jingwei Zheng; Tao Li; Anwen Shao; Cesar Reis; Sheng Chen; Jianmin Zhang
Journal:  Cell Transplant       Date:  2018-06-05       Impact factor: 4.064

Review 6.  An Assessment on Ethanol-Blended Gasoline/Diesel Fuels on Cancer Risk and Mortality.

Authors:  Steffen Mueller; Gail Dennison; Shujun Liu
Journal:  Int J Environ Res Public Health       Date:  2021-06-28       Impact factor: 3.390

7.  Scriptaid Treatment Decreases DNA Methyltransferase 1 Expression by Induction of MicroRNA-152 Expression in Porcine Somatic Cell Nuclear Transfer Embryos.

Authors:  Shuang Liang; Ming-Hui Zhao; Jeong-woo Choi; Nam-Hyung Kim; Xiang-Shun Cui
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

8.  The expression of microRNA 146a in patients with ischemic stroke: an observational study.

Authors:  Hend G Kotb; Amal H Ibrahim; Eman F Mohamed; Omaima M Ali; Nagwa Hassanein; Dina Badawy; Ehab Abdelatty Aly
Journal:  Int J Gen Med       Date:  2019-08-09

9.  GeromiRs Are Downregulated in the Tumor Microenvironment during Colon Cancer Colonization of the Liver in a Murine Metastasis Model.

Authors:  Daniela Gerovska; Patricia Garcia-Gallastegi; Olatz Crende; Joana Márquez; Gorka Larrinaga; Maite Unzurrunzaga; Marcos J Araúzo-Bravo; Iker Badiola
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

10.  MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis.

Authors:  Yue Li; You Li; Yao Chen; Qian Xie; Ningning Dong; Yanjun Gao; Huan Deng; Chunhua Lu; Suihai Wang
Journal:  Cancer Cell Int       Date:  2017-11-07       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.